Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Custom Peptide Synthesis and Conjugation Services

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves the synthesis of custom peptides and their conjugation to dextramer platforms labeled with fluorescent tags such as phycoerythrin (PE), specifically for use in immune monitoring applications. The work requires precise chemical synthesis of peptides tailored to specific immunological targets, followed by their stable attachment to dextramer scaffolds to enable high-sensitivity detection of antigen-specific T cells. Barcode labeling is a critical component, allowing multiplexed tracking and identification of multiple peptide-MHC complexes within a single sample, which enhances the efficiency and throughput of immune response analysis. The project is intended to support advanced research tools used in immunology and vaccine development, particularly in the context of infectious disease and cancer immunotherapy studies. This subcontract is issued under the National Institutes of Health NIDA, part of the Department of Health and Human Services, and falls under NAICS code 325414 for pharmaceutical preparation manufacturing. The opportunity was posted on August 6, 2026, with a response deadline of August 13, 2026. There is no set-aside designation specified, and no physical place of performance or point of contact details are provided. The work is expected to be performed by a qualified vendor capable of meeting high-purity standards and regulatory compliance for research-grade reagents, with deliverables including fully characterized peptide-dextramer-fluorophore conjugates ready for downstream immune cell assays.

General Info

Custom peptide-dextramer-fluorophore conjugates for multiplexed immune monitoring in NIH NIDA-funded research.

Agency

Department Of Health And Human Services → National Institutes Of Health NidaView Agency

NAICS

325414 - Biological Product (except Diagnostic) ManufacturingView NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Nida
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Synthesis of custom peptides and their conjugation to dextramer platforms with fluorescent tags (e.g., PE), including barcode labeling for immune monitoring tools.

Similar Contracts

Same NAICS industry code

NAICS: 325414
New
DIBBS
Sterile Medical Kit Assembly and PackagingThe contract mandates the complete assembly, sterilization, and packaging of a 30-piece sterile facial wound closure kit, ensuring full compliance with military and medical standards. The final product must be contained within a two-compartment tray that includes a drape and be hermetically sealed to maintain sterility throughout storage and transport. All processes must adhere to stringent regulatory requirements for medical devices intended for use in field and surgical environments, with quality control measures rigorously applied at every stage from component integration to final packaging. The kit is destined for deployment under Department of Defense medical supply channels and must meet exacting specifications for reliability, safety, and readiness. Performance is to be executed at Malmstrom AFB, with a zip code of 59402-6701, and all work must be completed in accordance with the NAICS code 325414, which classifies the manufacturing of surgical and medical instruments. The opportunity is posted as a subcontract under the Medical Supply Chain MD Surg FSF, with a response deadline of August 11, 2026. The solicitation is open to qualified vendors capable of handling complex sterile assembly, validated sterilization processes, and compliant packaging systems that meet or exceed DoD and FDA guidelines. Timing and precision are critical, as the kits are intended for immediate use in combat or emergency medical scenarios where failure is not an option.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

2 days ago

DEADLINE

in 4 days
View Details
NAICS: 325414
New
DIBBS
TEST KIT, BACTERIA D
Solicitation # SPE2DS-26-T-310W
The contract is for the procurement of 25 units of the API 20 E test kit, designed for the identification of Enterobacteriaceae and other gram-negative rods, under the NSN 6550-01-507-3726. Each purchase group (PG) equals 25 units, and the full order consists of exactly one PG. The product must be delivered within five days of contract award, with delivery terms specified as FOB destination, and no quantity variance is permitted. Strict shelf-life requirements apply: no more than three months may have elapsed from the date of manufacture to the date of delivery, and the item has a non-extendable shelf life of 18 months, classified as a TYPE I CODE K item. The test kits require refrigerated storage between 2 and 8 degrees Celsius at all times. Packaging must comply with commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with each unit sealed in protective containers and shipped in suitable exterior packaging to ensure safe delivery at the lowest freight rate. The product is regulated by the FDA, and the contracting official must submit a referral via EBS for confirmation, including manufacturer and part number details. The manufacturer is bioMérieux Inc with part number 20100. Technical and quality requirements are governed by the DLA Master List, and packaging, marking, and information security controls, including potential covered defense information, are mandated per applicable DLA directives. All documentation and compliance must align with the solicitation SPE2DS-26-T-310W, issued under NAICS code 325414 by the Department of Defense.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

2 days ago

DEADLINE

in 4 days
View Details
NAICS: 325414
New
Federal
Automated Microbiology Reagent and Consumables SupplyThe contract seeks ongoing supply of FDA-cleared reagents, consumables, and test kits specifically tailored for automated microbiology systems, with a focus on VITEK 2 XL reagents and saline solutions, ensuring continuous operational reliability for clinical and diagnostic laboratories. Deliveries will occur under recurring requirements, indicating a long-term, steady demand to support routine testing and patient care workflows without interruption. The procurement is structured as a subcontract, with no set-aside designation, and falls under the NAICS code 325414 for medical and surgical and medical appliance manufacturing, emphasizing the specialized nature of the products required. Issued by the Department of Veterans Affairs through the 248-NETWORK Contract Office 8, the opportunity was posted on August 5, 2026, with responses due by August 19, 2026. The place of performance and exact office address are unspecified, suggesting the supplies will be distributed across multiple VA medical facilities or centralized distribution points. The contract does not identify a point of contact, and the solicitation number is not provided, indicating potential internal routing within the VA’s procurement system. The focus on FDA-cleared items ensures compliance with regulatory standards for clinical use across veteran healthcare services.
248-NETWORK Contract Office 8 (36C248)

POSTED

2 days ago

DEADLINE

in 12 days
View Details
NAICS: 325414
New
DIBBS
Sterile Medical Dressing Manufacturing & PackagingThe contract requires the manufacture, sterilization, packaging, and labeling of adhesive petrolatum gauze dressings measuring 3x18 inches, all in full compliance with federal medical and defense standards. The product must be sterile-sealed and prepared for commercial shipping, ensuring readiness for immediate field use. Delivery is specified for Fort Hood, Texas, with packaging and labeling meeting exact military logistics and inventory requirements. The manufacturing process must adhere to stringent quality and safety protocols to support the Department of Defense’s medical supply chain, particularly for surgical and wound care applications in operational environments. This subcontract, posted on August 4, 2026, has a response deadline of August 10, 2026, and falls under NAICS code 325414 for medical and surgical manufacturing. The contracting entity is the Medical Supply Chain MD Surg FSF under the Department of Defense. No set-aside provision is specified, indicating open competition among qualified suppliers. All work must ensure traceability, sterility integrity, and compliance with federal regulations governing medical devices and defense procurement, with no deviations permitted in materials, processing, or packaging methods. Failure to meet any technical or logistical requirement will result in non-compliance and potential disqualification.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

3 days ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 325412
New
Federal
Government Contracting Compliance & GSA Schedule SupportThe contract solicits the supply of biotechnology reagents through existing GSA Schedule or GWAC vehicles, requiring full compliance with the Federal Acquisition Regulation for pricing and delivery terms. All offerings must leverage pre-negotiated, FAR-compliant contractual mechanisms to ensure transparency, affordability, and efficiency in procurement by the National Institutes of Health, specifically the National Institute on Drug Abuse under the Department of Health and Human Services. The NAICS code 325412 confirms the primary focus on pharmaceutical and biological product manufacturing, indicating the need for high-purity, research-grade reagents suitable for scientific and clinical applications. Responses must be submitted by August 13, 2026, and the contract is structured as a subcontract, implying the awardee will fulfill obligations under a prime contract holder rather than directly with the government. Performance is expected to align with federal supply chain standards, though no specific place of performance or set-aside criteria are provided. Compliance with GSA Schedule or GWAC terms is mandatory, ensuring that pricing remains consistent with established federal rates and that delivery timelines meet agency operational needs. The solicitation underscores the importance of proven regulatory adherence and reliable supply chain execution to support critical biomedical research activities.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
Federal
Specialty Biotech Reagent Manufacturing (dCODE Dextramer®)The contract involves the manufacture of specialized immunology reagents based on dextramer technology, specifically customizable HLA-peptide complexes equipped with fluorescent barcoding, intended for use in research and clinical applications. These reagents are designed to enable precise detection and analysis of antigen-specific T cells, supporting advancements in immunological studies and potential therapeutic development. The production must meet stringent quality and consistency standards to ensure reliability across diverse experimental and diagnostic settings, with an emphasis on scalability and customization to accommodate varying peptide and HLA combinations. This is a subcontract under the National Institutes of Health, specifically the National Institute on Drug Abuse, part of the Department of Health and Human Services, with the NAICS code 325412 indicating biological product manufacturing. The opportunity was posted on August 6, 2026, and responses are due by August 13, 2026, with no set-aside classification specified. The place of performance and other location details are not provided, indicating flexibility in where the manufacturing may occur, though all work must comply with the technical and regulatory requirements for clinical-grade reagents. The focus is squarely on advanced biotech manufacturing capabilities, emphasizing precision, reproducibility, and compliance with industry best practices for immune monitoring tools.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 488190
New
Federal
Biotech Logistics and Cold Chain DistributionThe contract calls for specialized logistics services focused on the packaging, labeling, and shipment of temperature-sensitive biologic reagents requiring stringent cold chain protocols, including maintenance at -80°C throughout运输. The work involves rigorous compliance with controlled environmental standards to preserve sample integrity, ensuring that all handling, documentation, and transport adhere to industry-specific biologic shipment requirements. This subcontract is issued under the NAICS code 488190, which covers other support activities for air transportation, indicating a need for highly coordinated, specialized distribution beyond standard freight services. The National Institutes of Health, specifically NIDA under the Department of Health and Human Services, is the agency overseeing this procurement with a response deadline of August 13, 2026. While the exact place of performance is not specified, the nature of the work implies coordination across multiple facilities and potentially international points of delivery. Bidders must demonstrate proven experience in cold chain management for biologics, including validated packaging solutions, real-time temperature monitoring, contingency protocols for deviations, and compliance with regulatory expectations for biological material transport. All proposals must be submitted by the stated deadline to be considered for award.
Other Support Activities for Air Transportation

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 334516
New
Federal
Repair and Installation services for the Heat Exchanger System on a Bruker 9.4 Tesla Magnetic Resonance Imaging (MRI) system
Solicitation # 75N98026Q00967
The National Institutes of Health, National Institute on Drug Abuse’s Intramural Research Program is conducting market research to identify qualified sources capable of providing emergency repair parts and installation services for the Triple-loop Heat Exchanger System on its Bruker 9.4 Tesla Magnetic Resonance Imaging scanner, which has failed and requires immediate replacement to prevent catastrophic magnet quenching. The requirement specifies a brand-name or equal heat exchanger that must interface seamlessly with the existing scanner software, building water supply, magnet cryomech, gradient, and shim coil cooling systems while ensuring stable cryomech operation and maintaining magnet pressure at 1040 mbar. All components must be new, unused, original equipment manufacturer parts authorized by Bruker Corporation, and installation must be performed exclusively by Bruker-certified technicians to preserve the MRI system’s existing warranty. The contractor must deliver and install the system within three months of order receipt, with a one-year warranty covering all parts, labor, travel, and including one preventative maintenance visit. Responses to this sources-sought notice must be submitted electronically by August 12, 2026, and must include detailed capability statements addressing each technical requirement separately, with supporting documentation on company size status under NAICS Code 334516, employee count, personnel qualifications, relevant government contracts, and complete contact and SAM.gov registration information including UEI and TIN. The notice explicitly states that no award will result from this action and that responses are not proposals or quotations. Companies must identify the place of manufacturing and confirm compliance with the Non-Manufacturer Rule if applicable. Proprietary or sensitive data should not be included, though any claimed proprietary information will be safeguarded. Responses are limited to ten pages excluding cover page and references, must reference solicitation number 75N98026Q00967SB, and be sent exclusively to Josh Lazarus at josh.lazarus@nih.gov. All respondents must have an active SAM.gov registration, and while small businesses are strongly encouraged to respond, the government retains full discretion on whether to pursue a competitive or non-competitive acquisition path based on the feedback received.
Analytical Laboratory Instrument Manufacturing

POSTED

1 day ago

DEADLINE

in 5 days
View Details